Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Microarray Analysis Market is all set to increase itself to a valuation of USD 4.64 billion by 2030 at a CAGR of 6.9% during the forecast period. There are several factors operating within the Microarray Analysis Marketplace in a changing environment like the growth or stagnation of that market. Microarray analysis, a highly efficient genome research tool, is the most popular one that can evaluate simultaneously thousands of gene expressions to achieve the required knowledge of various biological processes. The market tends to be dictated by the growing demand for better and improved genomic technologies that can offer great throughput in diagnosis, significant breakthroughs in microarray platforms, as well as the ever expanding scope of applications in fields like personalized medicine and biomarker identification.
The Microarray Analysis Market is highly influenced by innovation and research and development that are the major driving forces in increasing the growth of the market. Biotech companies, universities or research groups are involved actively in developments and improvements of microarray technologies to increase sensitivity and specificity as well as create more accurate data analysis guarantee. Consistent on-going upgrades of probe pattern, advanced microarray making, and bioinformatics application systems continue to broaden the use of microarray analysis that invariably result in favorable market dynamics. Increasingly microarray technologies find their way to more advanced versions which, in turn, are to serve the goal of further development of this industry.
The adoption of technology also changes the landscape of microarray data analysis. Novelties of microarrays, in particular the formation of bead-based arrays, digital microarrays, and whole-genome arrays, increase specificity and the analysis of genomes up to a new level. Besides the advance in the data analysis algorithm and integrating the other omics technology, overall, the research outputs to be more complete and relevant. These innovative microarray technologies not only expand the capabilities of the analysis platforms but also help the market to develop in for the scientists who are searching for the advanced equipment for the in-depth analysis of the genetic information.
Problem of microarray analysis consist in regulatory considerations, as well as standardization issues that are influencing market perspectives. The traditional way of doing things are replaced by new techniques and policy, hence the reliability and reproducibility of results of these methods are ensured. The market credibility is directly linked with the adherence to these standards here. The main goal of standardization trends is to ensure compliance with the standard for experiment design, data handling and result interpretation. The result can be said to affect the dynamics of the industry. Businesses operating in the microarray analysis field, however, work strategically and responsibly in regard to the applicable regulations to ensure the quality of their products and services and to be able to stay compliant with institutional and state regulations.
Another important in making the biotechnology market dynamics is competition among the biotechnology firms as well as the providers for microarray analysis services. Firms implement different tactics to fortify their respective market foothold and come up with wide-range of solutions based on microarrays technologies. Some of the tactics employed include collaborations, mergers & acquisitions and expanding the offered products.
Microarray Analysis Market Highlights:
Global Microarray Analysis Market Overview
The Microarray Analysis Market is expected to reach USD 4649.01 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030. The microarray analysis market is expected to witness tremendous growth during the forecast period. Microarray analysis is a molecular biology technique that uses microchips containing attached short DNA segments which are used for the analysis of gene expression on a large scale. This enables medical practitioners to decide the most effective treatment for individual patients. Microarray analysis can be used in various experiments such as epigenetics, genotyping, biomarker profiling, translation profiling, pathway identification mutations, and gene expression profiling. The techniques allow the scientists to analyze several genes at a time with accurate results. The rising prevalence of genetic disorders, increased focus on drug discovery and development, and rising demand for personalized medicines are driving the market growth. According to the Genetic Disorders UK 2017, every year approximately 30,000 new born children are diagnosed with genetic diseases. Microarray analysis helps in understanding the gene patterns in different types of tumors. They are also used for detection of cancer biomarker and also for its research. Hence the rising prevalence of cancer and increasing investments for cancer research can drive the market growth.
However, factors such as high costs of diagnosis, contamination, and inaccurate results are expected to hinder the market growth during the forecast period
Microarray Analysis Market Segment Insights
The global microarray analysis market is segmented on the basis of type, application, product type, and end-user. The global microarray analysis market, by type, is segmented into DNA microarrays, protein microarrays, tissue microarrays, cellular microarrays, chemical compound microarrays, glycan arrays, and phenotype microarrays. The application segment is segmented into research, genotyping, forensic analysis, proteomics, genomics, disease diagnosis, drug discovery, and toxicological research. The product type segment is further sub-segmented into reagents, primers, buffers, DNA chips, reagent kits, and instruments. The instrument category consists of scanner, hybridization oven, Multi-Channel (MC) instrument, target preparation instrument, slide imprinters, centrifuge, and others. On the basis of end-user, the market is categorized into pharmaceuticals, biotechnology, hospitals and clinics, diagnostic centers, academic and research institutes, and ambulatory care centers.
On the basis of region, the global microarray analysis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players for the global microarray analysis market are Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied Microarrays. Other companies operating in the global microarrays market are biomerieux SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, PLC, Thermo Fisher Scientific, and ProteoGenix.
Regional Market Summary
Global Microarray Analysis Market Share (%), by Region
Sources: National Cancer Institute, World Health Organization, European Commission, ALZHEIMER'S DISEASE INTERNATIONAL
The microarray analysis market is dominated by the Americas owing to the adoption of advanced technology for diagnosis, awareness among people for better diagnostics, and high investments in research. The National Cancer Institute received USD 5.665 billion from the States Congress for cancer research programs in 2018.
It is estimated that Europe was the second largest in the global microarray analysis market. The rising focus on drug discovery, personalized medicines, and targeted therapy are driving the growth of the market in this region. In November 2016, over 30 European and international members along with the European Commission established an initiative called the International Consortium for Personalized Medicine, or "ICPerMed" to establish Europe as a global leader in personalized medicine research. Thus, the increasing research in personalized medicines serves favorable backgrounds for the market to grow in this region.
The microarray analysis market in Asia-Pacific is expected to witness growth owing to rising prevalence of genetic disorders, growing awareness among the people, and government initiatives. According to Alzheimer's Disease International, in 2015, 23 million people in the Asia-Pacific region had dementia, and by 2050 the number is expected to rise to 71 million.
The Middle East and Africa holds the least share in the global microarray analysis market due to low funding in medical and health research. However, the rising prevalence of genetic diseases and increasing healthcare spending favor the market growth in this region.
Intended Audience
- Hospitals
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Market Segmentation and Key Market Players
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Sequenom, Inc
- Roche NimbleGen
- Illumina, Inc
- Applied Microarrays
- Biomerieux SA,
- Discerna,
- Gyros AB,
- Luminex Corporation,
- NextGen Sciences, PLC.,
- Thermo Fisher Scientific
- ProteoGenix
Microarray Analysis Market Segmentation
Microarray Analysis Type Outlook
- DNA microarrays
- Protein microarrays
- Tissue microarrays
- Cellular microarrays
- Chemical compound microarrays
- Antibody microarrays
- Glycan arrays
- Phenotype microarrays
Microarray Analysis Application Outlook
- Research
- Genotyping
- Forensic Analysis
- Proteomics
- Genomics
- Disease Diagnosis
- Drug Discovery
- Toxicological Research
Microarray Analysis Product Type Outlook
- Reagents
- Primers
- Buffers
- DNA chips
- Reagent kits
- Instruments
- Scanner
- Hybridization Oven
- Multi-Channel (MC) Instrument
- Target Preparation Instrument
- Slide Imprinters
- Centrifuge
Microarray Analysis End-User Outlook
- Pharmaceuticals
- Biotechnology
- Hospitals & Clinics
- Ambulatory Care Centers
- Diagnostic Centers
- Academic and Research Institutes
Microarray Analysis Region Outlook
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
